PACB stock gains on Lucid Genomics deal, boosting HiFi data analysis and simplifying workflows to speed insights and expand ...

PacBio’s Compatible partner program recognizes third-party providers whose solutions have been evaluated to work seamlessly with PacBio instruments and data formats. As a named partner, Lucid Genomics ...

The workflow leverages Covaris’ Adaptive Focused Acoustics ® (AFA)-based truXTRAC FFPE extraction method to recover longer DNA fragments, up to 5,000 base pairs, from FFPE tissues. PacBio’s Kinnex ...

Pacific Biosciences of California (PACB) ended the recent trading session at $1.71, demonstrating a -1.16% change from the preceding day's closing price. The stock trailed the S&P 500, which ...

(RTTNews) - PacBio (PACB), a developer of highly accurate sequencing solutions, is slated to participate in several upcoming investor conferences this month, underscoring its visibility within the ...

MENLO PARK, Calif., Sept. 22, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, today announced its entry into the ...

Pacific Biosciences of California Inc. (NASDAQ:PACB) is one of the 8 Best Life Sciences Penny Stocks to Buy. On March 18, ...

MENLO PARK, Calif., March 05, 2026 (GLOBE NEWSWIRE) -- PacBio (PACB), a leading provider of high-quality, long-read sequencing technologies, today announced the appointment of Christopher Gibson, Ph.D ...

In the latest trading session, Pacific Biosciences of California (PACB) closed at $1.60, marking a +1.91% move from the previous day. The stock exceeded the S&P 500, which registered a gain of 0.8% ...